ArticlePloS one2024

Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis.

Sudewi Mukaromah Khoirunnisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.